Morgan Stanley Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock
AbbVie (NYSE:ABBV – Get Free Report) had its price objective increased by Morgan Stanley from $241.00 to $250.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 29.17% from the company’s current price. Other equities research analysts have […]
AbbVie (NYSE:ABBV – Get Free Report) had its price objective increased by Morgan Stanley from $241.00 to $250.00 in a report issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 29.17% from the company’s current price. Other equities research analysts have […]
